Bain Capital Life Sciences Investors, LLC

13F Portfolio Filings

Most recent 13F
Q3 2024
Location
Boston, MA
CIK
0001703031
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2024 24 961,175 NUVL, NAMS, IRON, DNTH 13F-HR 11/14/2024 000095012324011417
Q2 2024 25 910,841 NUVL, NAMS, IRON, DNTH 13F-HR 8/12/2024 000095012324007830
Q1 2024 26 1,244,287 NAMS, NUVL, DNTH, IRON 13F-HR 5/15/2024 000095012324005471
Q4 2023 27 1,043,257 NUVL, NAMS, PHVS, IRON 13F-HR 2/13/2024 000095012324001898
Q3 2023 31 894,220 NUVL, PHVS, NAMS, SWTX 13F-HR 11/14/2023 000095012323010856
Q2 2023 32 970,993 NUVL, NAMS, SWTX, PHVS 13F-HR 8/14/2023 000095012323008184
Q1 2023 34 800,117 NAMS, NUVL, SWTX, IRON 13F-HR 5/15/2023 000095012323005321
Q4 2022 33 894,849 SWTX, NUVL, NAMS, NTRA 13F-HR 2/14/2023 000095012323002178
Q3 2022 33 837,757 SWTX, NUVL, MRSN, ARQT 13F-HR 11/14/2022 000095012322012270
Q2 2022 35 852,695 SWTX, DVAX, PHVS, ARQT 13F-HR 8/15/2022 000095012322009430
Q1 2022 34 1,029,621 SWTX, DVAX, ARQT, PHVS 13F-HR 5/16/2022 000095012322006412
Q4 2021 34 1,260,974 SWTX, DVAX, RPID, ARQT 13F-HR 2/14/2022 000095012322002471
Q3 2021 33 1,612,006 SWTX, DVAX, RPID, AVIR 13F-HR 11/15/2021 000095012321015534
Q2 2021 30 1,526,199 SWTX, AVIR, DVAX, DRNA 13F-HR 8/16/2021 000095012321011522
Q1 2021 31 1,765,308 SWTX, AVIR, ARQT, DVAX 13F-HR 5/17/2021 000095012321006704
Q4 2020 26 1,592,801 SWTX, AVIR, ARQT, MRSN 13F-HR 2/16/2021 000095012321002146
Q3 2020 22 1,072,931 SWTX, ARQT, ANNX, DRNA 13F-HR 11/16/2020 000095012320011923
Q2 2020 15 954,774 SWTX, ARQT, DRNA, DVAX 13F-HR 8/14/2020 000095012320008777
Q1 2020 11 591,296 SWTX, ARQT, DRNA, CNST 13F-HR 5/15/2020 000095012320005061
Q4 2019 10 670,536 SWTX, CNST, DRNA, DVAX 13F-HR 2/14/2020 000095012320002136
Q3 2019 7 388,402 SWTX, DRNA, SLDB, REPL 13F-HR 11/14/2019 000095012319011059
Q2 2019 5 196,868 DRNA, REPL, MRNS, SLDB 13F-HR 8/14/2019 000095012319007984
Q1 2019 6 250,119 DRNA, REPL, IFRX, MRNS 13F-HR 5/15/2019 000095012319005099
Q4 2018 6 292,636 DRNA, IFRX, SLDB, APTX 13F-HR 2/14/2019 000095012319001853
Q3 2018 6 440,629 DRNA, SLDB, APTX, IFRX 13F-HR 11/14/2018 000095012318011520
Q2 2018 5 319,135 DRNA, SLDB, IFRX, APTX 13F-HR 8/14/2018 000095012318008490
Q1 2018 4 169,604 DRNA, IFRX, MRNS, SLDB 13F-HR 5/15/2018 000095012318005392
Q4 2017 3 152,407 DRNA, IFRX, MRNS 13F-HR 2/14/2018 000095012318001950